Meeting
2019 ASCO Annual Meeting
Biomarker analysis of PALLET: A neoadjuvant trial of letrozole (L) ± palbociclib (P).
Authors
Vera Martins
ICR, London, United Kingdom
Vera Martins , Lucy Kilburn , Andrew Dodson , Arjun Modi , Katherine L. Pogue-Geile , Mothaffar F. Rimawi , Shannon Leigh Huggins-Puhalla , Cynthia Huang Bartlett , Sophie Perry , Leona Batten , C. Kent Osborne , Samuel A. Jacobs , Stephen R. D. Johnston , Judith Bliss , Mitchell Dowsett
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Local/Regional/Adjuvant
Track
Breast Cancer
Sub Track
Neoadjuvant Therapy
Clinical Trial Registration Number
NCT02296801
Citation
J Clin Oncol 37, 2019 (suppl; abstr 570)
DOI
10.1200/JCO.2019.37.15_suppl.570
Abstract #
570
Poster Bd #
62
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Primary efficacy analyses of NeoRHEA, neoadjuvant biomarker research study of palbociclib combined with endocrine therapy in estrogen receptor positive/HER2 negative breast cancer.
First Author: Elisa Agostinetto
Poster
2021 ASCO Annual Meeting
The association of HER2 low expression with the efficacy of CDK4/6 inhibitor in hormone receptor positive HER2 negative metastatic breast cancer.
First Author: Kelvin K H Bao
Poster
2019 ASCO Annual Meeting
In-depth gene expression analysis of premenopausal patients with HR+/HER2− advanced breast cancer (ABC) treated with ribociclib-containing therapy in the Phase III MONALEESA-7 trial.
First Author: Yen-Shen Lu
